-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Paulina Ibarra
Biotech Business: Wait Our Model Isn’t Dead
Life sciences company and investment executives debated the current and future viability of the industry model for startup companies, given the tumultuous economic waters it traversed during the so-called Great Recession of 2008-2009. The aptly-named panel (“Wait, Our Model Isn’t Dead! We Just Need to Evolve”) appraised those lean times for biotech in a justifiable effort to explain the dramatic decline of startup generation and flow of available investment funding since the peak of the Read More >
Biotechnology – Creating a positive political and social environment
“I think it’s important that government stands up for proper science,” Former British Prime Minister Tony Blair said during the Tuesday keynote luncheon at the 2001 BIO International Convention. “You know I had a lot of battles over this when I was prime minister – with various groups.” This was a familiar story to many of the attendees who regularly face a number of social and political hurdles in bringing their innovative products to market: Read More >
Author of Building Biotechnology Onsite at the 2011 BIO International Convention
Yali Friedman, author of Building Biotechnology as well as other books is signing books at the BIO bookstore from 3pm to 4:30pm at the 2011 BIO International Convention.
Thoughts on the Partnering for Global Health Forum
Angie Drakulich posts on PharmTech Talk her thoughts on the Partnering for Global Health Forum, being held at the 2011 BIO International Convention. The Forum presented a unique panel of government leaders from emerging markets, discussing what it takes to do business in their countries.
Biotech in the age of new media
In the age of new media, sharing information about a prescription drug is even more perilous than ever. Despite promises of guidelines in 2009, the FDA still has yet to issue clear guidance to pharmaceutical companies about how to remain in compliance with regulations while using the appealing and affordable medium of new media to disseminate information. In their panel, “Talking About Your Product in the New Age: Social Media and the Internet,” moderator John Read More >
